Skip to content

Acute Myocardial Infarction Study in Northeastern China

the Acute Myocardial Infarction Study in Northeastern China

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04451967
Enrollment
3159
Registered
2020-06-30
Start date
2019-09-09
Completion date
2022-09-09
Last updated
2020-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction

Brief summary

This is a real-world prospective cohort study aiming to generate knowledge about the characteristics, treatments, and outcomes of hospitalized AMI patients in Jilin Province. The study includes hospitalizations diagnosed of AMI, including ST segment-elevation myocardial infarction (STEMI) and non-ST-segment-elevation myocardial infarction (NSTEMI).

Interventions

PROCEDUREthrombolysis

transfer after thrombolysis for STEMI patients within 6h since onset

Sponsors

Yanbian University Hospital
CollaboratorUNKNOWN
Dunhua City Hospital in Jilin Province
CollaboratorUNKNOWN
Liaoyuan City Central Hospital
CollaboratorUNKNOWN
Dongliao People's Hospital
CollaboratorUNKNOWN
Songyuan Central Hospital
CollaboratorUNKNOWN
Changling People's Hospital
CollaboratorUNKNOWN
Siping Central People's Hospital
CollaboratorOTHER
The First People's Hospital of Manchu Autonomous County
CollaboratorUNKNOWN
Changchun Center Hospital
CollaboratorUNKNOWN
Nongan People's Hospital
CollaboratorUNKNOWN
Beihua University
CollaboratorOTHER
Jilin Hospital of Integrated Traditional Chinese and Western Medicine
CollaboratorUNKNOWN
Panshi City Hospital
CollaboratorUNKNOWN
Tonghua Central Hospital
CollaboratorUNKNOWN
Baishan Central Hospital
CollaboratorUNKNOWN
Jingyu People's Hospital
CollaboratorUNKNOWN
Meihekou Central Hospital
CollaboratorUNKNOWN
Baicheng Central Hospital
CollaboratorUNKNOWN
Tongyu First Hospital
CollaboratorUNKNOWN
Second Hospital of Jilin University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* patients admitted within 7 days of acute myocardial ischemic symptoms with a primary clinical diagnosis of AMI, meet Fourth Universal Definition for Myocardial Infarction (2018)

Exclusion criteria

* Types 4a and type 5 AMI

Design outcomes

Primary

MeasureTime frameDescription
all-cause death2 years post dischargeall-cause death

Secondary

MeasureTime frameDescription
major adverse cardiac events (MACE)2 years post dischargerecurrent angina, non-fatal myocardial infarction, cardiac failure, malignant arrhythmia, and death from cardiovascular causes

Countries

China

Contacts

Primary ContactTianyi Li, Ph.D
litianyi@jlu.edu.cn+8615843024731

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026